hPD-1/hCTLA-4(BALB/c)
品系全名
BALB/cJSmo-Pdcd1tm1(hPDCD1)Ctla4tm1(hCTLA4)Smoc
目录号
NM-HU-200277
品系状态
胚胎冻存
品系描述
验证数据
图1. hPD1/hCTLA4双人源化小鼠体内药效研究结果示例。K药、O药、Y药均可抑制CT26-hPD-L1移植瘤在hPD1/hCTLA4双人源化小鼠皮下的生长，上述数据表明hPD1/hCTLA4双人源化小鼠模型是进行免疫药物筛选的有效工具。
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
